Peptides / Liraglutide
Liraglutide
(Victoza, Saxenda)T1glp1clinical
Biomarker Effects
No biomarker data available yet.
Dosing & Pharmacokinetics
Typical Dose0.6 mg
Frequencydaily
Routeclinician-directed
Half-Life13 hr
Safety & Evidence
Liraglutide is a GLP-1 receptor agonist approved for type 2 diabetes (Victoza) and obesity (Saxenda). Administered as daily injection.
Sources
Track Liraglutide precisely in the Vivy app.
Your precision instrument awaits.
Download Vivy